Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
30%
OVERLAP
BY WEIGHT
10
# OF OVERLAPPING
HOLDINGS
FHLC
349
HOLDINGS
3%
ALSO IN THNR
THNR
20
HOLDINGS
50%
ALSO IN FHLC
SECTOR DRIFT (FHLC minus THNR)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FHLC |
Weight in THNR |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 11.3% | 11.4% | 11.3% |
|
ABBVIE INC | 6.1% | 5.7% | 5.7% |
|
MERCK & CO. INC. | 3.8% | 5.5% | 3.8% |
|
AMGEN INC | 2.8% | 6.8% | 2.8% |
|
PFIZER INC | 2.4% | 5.4% | 2.4% |
FHLC Overweight Relative to THNR
|
UNITEDHEALTH GROUP INC | 7.3% |
|
JOHNSON & JOHNSON | 6.4% |
|
ABBOTT LABORATORIES | 3.8% |
|
THERMO FISHER SCIENTIFIC INC | 3.3% |
|
INTUITIVE SURGICAL INC | 3.0% |
|
BOSTON SCIENTIFIC CORP | 2.3% |
|
DANAHER CORP | 2.2% |
|
STRYKER CORP | 2.1% |
|
VERTEX PHARMACEUTICALS INC | 2.0% |
|
BRISTOL-MYERS SQUIBB CO | 2.0% |
FHLC Underweight Relative to THNR
 |
NOVO-NORDISK A/S-SPONS ADR | -9.1% |
|
REGENERON PHARMACEUTICALS | -6.6% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -5.6% |
 |
ASTRAZENECA PLC-SPONS ADR | -5.6% |
 |
INNOVENT BIOLOGICS, INC. | -5.2% |
 |
ROCHE HOLDING LTD | -5.0% |
 |
CHINA PHARMACEUTICAL GROUP | -4.9% |
|
SHIONOGI & CO LTD | -4.3% |
|
AMGEN INC | -4.0% |
|
HIMS & HERS HEALTH, INC. CLASS A | -3.2% |